Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8442 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8311 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.8235 |
Intermediate Similarity |
NPD37 |
Approved |
0.8194 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8194 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8194 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8156 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8121 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8113 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8112 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.8108 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.8108 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.8075 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8028 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7987 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7986 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7917 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7867 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7848 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7793 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7785 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7771 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7738 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7724 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7724 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7722 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7698 |
Intermediate Similarity |
NPD17 |
Approved |
0.7687 |
Intermediate Similarity |
NPD228 |
Approved |
0.7687 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7677 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7676 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7639 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7636 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7632 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7622 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7619 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.761 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7589 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7586 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7576 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.756 |
Intermediate Similarity |
NPD7240 |
Approved |
0.755 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD5763 |
Approved |
0.755 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7548 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7537 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7537 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7533 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1512 |
Approved |
0.75 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2797 |
Approved |
0.75 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7484 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7448 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7439 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7436 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7434 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7434 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7434 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7429 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7421 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7381 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7378 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7376 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7375 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7375 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7372 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7365 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7347 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7343 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7338 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7333 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7317 |
Intermediate Similarity |
NPD919 |
Approved |
0.7303 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7294 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7267 |
Intermediate Similarity |
NPD826 |
Approved |
0.7267 |
Intermediate Similarity |
NPD825 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7261 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD987 |
Approved |
0.7257 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7255 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7255 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7254 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7246 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7241 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7237 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7235 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7203 |
Intermediate Similarity |
NPD1778 |
Approved |
0.72 |
Intermediate Similarity |
NPD6663 |
Approved |
0.72 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7186 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7178 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7175 |
Intermediate Similarity |
NPD7296 |
Approved |
0.7172 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7162 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD5736 |
Approved |
0.716 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7158 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1501 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7134 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7125 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7123 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD4359 |
Approved |
0.7122 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7115 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7115 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7114 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7092 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD7315 |
Approved |
0.7083 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7081 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2370 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD3687 |
Approved |
0.708 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7078 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7052 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7049 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7048 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7039 |
Intermediate Similarity |
NPD943 |
Approved |
0.7037 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.703 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7027 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7027
|
Intermediate Similarity |
NPD4583 |
Approved |